OTC · TNPH
Tian'an Pharmaceutical Co., Ltd.
$0.03$0.00 (0.0%)
Tian'an Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 38.78% below the high.
Loading market information…
OTC · FLHLF · USD
Stock price, earnings
Quote as of Apr 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 99.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Filament Health Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Filament Health Corp. is a pioneering company dedicated to the discovery and extraction of natural psychedelic compounds. Its operations encompass the cultivation of psychedelic plants, genetic research, advanced extraction methodologies, and the conduct of internal clinical trials. Furthermore, the firm licenses its intellectual property and potential drug substances to pharmaceutical developers, scientific researchers, and other authorized entities. The company's principal office is located in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $249.15K+59.28% vs estimate |
| Q2 2023 | Aug 15, 2023 | -$0.01 | $47.15K |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.03$0.00 (0.0%)
Tian'an Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 38.78% below the high.
$0.00-$0.00 (-16.67%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.55% below the high.
$0.00$0.00 (0.0%)
Nutranomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Kali, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Cannonau Corp.’s quoted price sits in the lower half of its reported 52-week range, 99.5% below the high.
$0.00$0.00 (0.0%)
Curative Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Amazonas Florestal, Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Acura Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
